Nephrocare Health IPO
ListedNEPHROPLUS
Nephrocare Health IPO, a Mainboard IPO was listed on the exchange on December 17, 2025. The price band is set between ₹438 –460 , with a face value of ₹2 . Retail investors can apply with a minimum of 1 lot, each comprising 32 shares — amounting to ₹14,720 at the upper price.
Nephrocare Health IPO has been successfully listed on the exchange. Track the listing performance, current stock price, and post-listing trends. This information is for education only—not investment advice.
Nephrocare Health IPO MAINBOARD Important Dates
Get important updates regarding Nephrocare Health IPO MAINBOARD tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates. Dates are updated as soon as they are announced.
IPO Timeline
Open Date
Dec 10
Close Date
Dec 12
Allotment
Dec 15
Listing
Dec 17
Price Band & Investment Details
Issue Size
₹871.04 Cr
Issue Price
₹438 – ₹460
Face Value
₹2/share
Market Lot
32 shares
Retail Min Investment
₹14,720
Listing At
NSE,BSE
Sale Type
both
Fresh Issue
₹353.4 Cr
Offer for Sale
₹517.64 Cr
Issue Type
book building
Nephrocare Health IPO IPO Grey Market Premium (GMP) - Live Rates & Current Status
Last updated: 1 month ago
Nephrocare Health IPO IPO GMP Historical Data - Complete Track Record
| Date | IPO Issue Price (₹) | GMP (₹) | Est. Listing Price (₹) | Est. Profit Amount (₹) | Est. Profit % | Last Updated |
|---|---|---|---|---|---|---|
| 17 Dec 2025 Latest | ₹460 | ₹40 | ₹500 | ₹40 |
8.7%
|
12:00 PM |
| 16 Dec 2025 | ₹460 | ₹37 | ₹497 | ₹37 |
8.04%
|
12:00 PM |
| 15 Dec 2025 | ₹460 | ₹37 | ₹497 | ₹37 |
8.04%
|
12:00 PM |
| 14 Dec 2025 | ₹460 | ₹34.5 | ₹494.5 | ₹34.5 |
7.5%
|
12:00 PM |
| 13 Dec 2025 | ₹460 | ₹33 | ₹493 | ₹33 |
7.17%
|
12:00 PM |
| 12 Dec 2025 | ₹460 | ₹33 | ₹493 | ₹33 |
7.17%
|
12:00 PM |
| 11 Dec 2025 | ₹460 | ₹11.5 | ₹471.5 | ₹11.5 |
2.5%
|
12:00 PM |
| 10 Dec 2025 | ₹460 | ₹20 | ₹480 | ₹20 |
4.35%
|
12:00 PM |
Subscription (Latest Snapshot)
View Detailed SubscriptionLatest snapshot: Dec 17, 2025
| Category | Subscribed (x) |
|---|---|
| QIB | 16.01x |
| NII | 17.87x |
| bNII (bids above ₹10L) | 22.01x |
| sNII (bids below ₹10L) | 9.58x |
| Retail Investors | 1.68x |
| Total | 9.15x |
Registrar
- Registrar
- KFin Technologies Limited
- Registrar Phone
- + 91 40 6716 2222
- Registrar Email
- nephrocare.ipo@kfintech.com
- Registrar Address
- Selenium, Tower-B Plot No. 31, Financial District Nanakramguda, Serilingampally, Rangareddi Hyderabad, Telangana, 500 032 India
Nephrocare Health IPO Investment Limits
IPO investment limits, also referred to as application limits or bidding limits, define the minimum and maximum number of shares, lots, and investment amount that investors can apply for in an IPO based on their category (Retail, HNI, or Institutional). These limits are calculated as per SEBI guidelines and help ensure fair distribution of shares. Retail investors typically have lower minimum and maximum limits compared to High Net Worth Individuals (HNI) and Non-Institutional Investors (NII). Understanding IPO application limits is essential for investors to determine how much they can invest, calculate the number of lots they can apply for, and plan their investment strategy accordingly. The investment limits table shows the lot size, number of shares, and total amount in rupees for each investor category.
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 32 | ₹14,720 |
| Retail (Max) | 13 | 416 | ₹191,360 |
| S-HNI (Min) | 14 | 448 | ₹206,080 |
| S-HNI (Max) | 67 | 2,144 | ₹986,240 |
| B-HNI (Min) | 68 | 2,176 | ₹1,000,960 |
IPO Reservation
The IPO reservation structure, also known as share allocation breakdown, details how the total issue size is distributed among different investor categories as mandated by SEBI (Securities and Exchange Board of India) regulations. This reservation table shows the exact percentage and number of shares allocated to Qualified Institutional Buyers (QIB), Retail Individual Investors (RII), High Net Worth Individuals (HNI), Non-Institutional Investors (NII), and other reserved categories like employees and shareholders. Understanding IPO reservation percentages is crucial for investors to evaluate their probability of share allotment, as each category has different subscription levels and competition. The maximum allottees column indicates the cap on the number of investors who can receive shares in each category, helping you assess the likelihood of getting an allotment based on your investor category.
| Category | Shares Offered | Maximum Allottees |
|---|---|---|
| QIB Shares Offered | 9,620,900 | NA |
| Total Shares Offered | 9,620,900 | — |
Nephrocare Health Services Overview
Nephrocare Health Services, operating under the brand NephroPlus, is India’s and Asia's largest dialysis service provider. It addresses the critical and growing need for accessible and high-quality renal care through an extensive network of centers.
-
Company Growth
-
Founded by: Vikram Vuppala (along with co-founders) in 2009, based in Hyderabad.
- Model: Operates an asset-light, scale-driven model focused on outsourcing and partnerships. A significant portion of its clinics operate under revenue-sharing arrangements within private hospitals (captive clinics) or through Public-Private Partnership (PPP) contracts with government agencies.
-
Scale (As of Sep 30, 2025):
-
Clinic Network: Operates 519 clinics globally, including 51 in international markets (Philippines, Uzbekistan, Nepal).
- Market Leadership: It is the largest dialysis service provider in Asia and ranks 5th globally by treatments performed in FY25. It holds over 50% market share of the organized Indian dialysis market.
- Treatments: Performed approximately 2.9 million dialysis treatments in FY25, serving roughly 10% of India's total dialysis patient base.
-
-
- Founded In
- 2009
- Managing Director
- Vikram Vuppala
- Headquarters
- 5th Floor, D Block, iLabs Centre, Plot 18 Software Units Layout, Survey No. 64, Shaikpet, Hyderabad, Telangana, India - 500081
- Website
- nephroplus.com
- Industry
- Healthcare
Frequently Asked Questions
What are the Nephrocare Health IPO dates?
The Nephrocare Health IPO is expected to open in December, 2025, subject to SEBI approval. Final dates will be updated once announced officially.
What is the price band of Nephrocare Health IPO?
The price band for Nephrocare Health IPO is ₹438.00 - ₹460.00 per share.
What is the GMP today for Nephrocare Health IPO?
As per market sources, Nephrocare Health IPO GMP is currently ₹40.00. GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.
How much subscription has happened for Nephrocare Health IPO?
The subscription status for Nephrocare Health IPO stands at 9.15x overall.
When is the Nephrocare Health IPO listing date?
The listing date for Nephrocare Health IPO is December 17, 2025.
Community Discussion
0 CommentsNo comments yet. Be the first to comment!
You may also like
